Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
Recruiting
N/A
Interventional Study
CABG
Myocardial Viability
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Klinički Bolnički Centar Zagreb · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Myocardial protection during surgical myocardial revascularization is crucial for reducing perioperative myocardial injury and improving postoperative outcomes. Blood cardioplegia represents the standard method in many centers, while del Nido cardioplegia, originally developed for the pediatric population, is increasingly being used in adult patients as well.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligibility Criteria:
1\. Patients with multivessel coronary artery disease scheduled for elective coronary artery bypass grafting
Exclusion Criteria:
1. Left ventricular ejection fraction \<30%
2. Associated cardiac procedures
3. Off-pump coronary artery bypass grafting
4. Contraindications for …
Contacts